RESEARCH-USE BIOSIMILAR ANTIBODY
Abelacimab
Monoclonal antibody · IgG1
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies.
TARGETF11
YMonoclonal antibody
CATALOGSC-BS-793
CATALOG NUMBERSC-BS-793
MOLECULAR WEIGHTApprox. 147.32 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Abelacimab (MAA868) is a fully human IgG1 monoclonal antibody that binds with high affinity to the catalytic structural domain of FXI and locks it in the zymogen conformation, thereby preventing its activation by FXIIa or thrombin. Abelacimab can be used in thromboembolic disease studies.
Abelacimab is a recombinant research-use antibody directed against F11.